RedHill Biopharma Profile

6.05
USD 0.05  0.83%
1%
64%

RedHill Biopharma Summary

RedHill Biopharma Ltd (RDHL) is traded on BATS Exchange in USA. It is located in ISRAEL and employs 74 people. RedHill Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 158.58 M. RedHill Biopharma Ltd conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 171.64 M outstanding shares of which 364.81 K shares are at this time shorted by private and institutional investors with about 3.94 trading days to cover. Redhill Biopharma currently holds about 36.35 M in cash with (43.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71.
Check RedHill Biopharma Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 6.05HorizonTargetOdds Above 6.05
12.65%30 days 6.05 87.30%
Based on normal probability distribution, the odds of RedHill Biopharma to move above current price in 30 days from now is about 87.3% (This RedHill Biopharma Ltd probability density function shows the probability of RedHill Biopharma Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Menora Mivtachim Holdings LtdCommon Shares421 K3.6 M
Migdal Insurance Financial Holdings LtdCommon Shares396.1 K3.4 M
View RedHill Biopharma Diagnostics

Selected RedHill Biopharma Ltd Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

RedHill Biopharma Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
49 
Equity ratings for RedHill Biopharma Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
RedHill Biopharma Ltd., a specialty biopharmaceutical company, focuses on the development and commercialization of late clinical-stage drugs for the treatment of gastrointestinal diseases. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 74 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
RedHill Biopharma SEC Filings
RedHill Biopharma SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameRedHill Biopharma Ltd
CEOOri ShiloView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
LocationISRAEL
Business Address21 Ha'arba'a Street
Foreign Associate  Israel
ExchangeBATS Exchange
CUSIPM8208M118
SectorHealthcare
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.redhillbio.com
Phone972 3 541 3131
CurrencyUSD - US Dollar

Directors

RedHill Biopharma Corporate Directors
Ofer Tsimchi Director
Shmuel Cabilly Director
Kenneth Reed Director
Additionally take a look at Your Equity Center. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.